STOCK TITAN

Dyne Therapeutics: Wellington reports 5.67% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Dyne Therapeutics, Inc. (DYN) was the subject of a Schedule 13G by Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP. Each reported beneficial ownership of 10,579,924 shares; Item 4 states the reported holding represented 5.67% of the class. The event date is September 30, 2026.

The first three entities each reported shared voting power over 9,963,952 shares and shared dispositive power over 10,579,924 shares. Wellington Management Company LLP reported shared voting power over 9,855,051 shares and shared dispositive power over 10,186,101 shares. The shares are owned of record by clients of the Wellington investment advisers.

Beneficial ownership reported by each reporting entity 10,579,924 shares Each of the four reporting entities listed this amount; the event date is September 30, 2026.
Ownership percentage 5.67% Percentage stated in Item 4.
Shared voting power 9,963,952 shares Reported by Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP.
Shared dispositive power 10,579,924 shares Reported by Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP.
Shared voting power 9,855,051 shares Reported by Wellington Management Company LLP.
Shared dispositive power 10,186,101 shares Reported by Wellington Management Company LLP.
Beneficially Owned regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DYN shares did the Wellington entities report owning?

The four reporting entities each listed beneficial ownership of 10,579,924 Dyne Therapeutics shares. Item 4 gives the ownership percentage as 5.67%.

Who has voting and dispositive power over DYN shares?

Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP each reported shared voting power over 9,963,952 shares and shared dispositive power over 10,579,924 shares. Wellington Management Company LLP reported shared voting power over 9,855,051 shares and shared dispositive power over 10,186,101 shares.

Who owns the DYN shares of record, and who receives dividends or sale proceeds?

The shares are owned of record by clients of one or more Wellington investment advisers. Those clients have the right to receive, or direct the receipt of, dividends or proceeds from sales of the shares; no client was identified as having that right or power over more than 5% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Group Holdings LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Investment Advisors Holdings LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Management Company LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026

Keep reading